Jim Cramer Weighs In On Valeant, Corning And Synergy Pharmaceuticals

Jim Cramer spoke on CNBC's Mad Money about Valeant Pharmaceuticals Intl Inc (NYSE:VRX). He thinks the company should do an equity offering to reduce its huge debt. There is still a large short position in the stock and some investors decided to cover it, because the downside is now quantified. He doesn't see Valeant as a good long position.

Cramer thinks Corning Incorporated (NYSE:GLW) is having a good run and the stock is a buy.

Cramer can't recommend Synergy Pharmaceuticals Inc (NASDAQ:SGYP) for anything other than a speculation. It's still in an early stage and it didn't report a good quarter.